Randomised Trial of Flush Saphenofemoral Ligation for Primary Great Saphenous Varicose Veins
| Autor: | Jonothan Earnshaw, B. P. Heather, C. Foy, R.J. Winterborn |
|---|---|
| Rok vydání: | 2008 |
| Předmět: |
Male
medicine.medical_specialty Femoral vein Neovascularization Physiologic Physical examination Varicose Veins Saphenofemoral ligation Recurrence Varicose veins Medicine Humans Saphenous Vein Single-Blind Method Saphenofemoral junction Ligation health care economics and organizations Ultrasonography Medicine(all) medicine.diagnostic_test business.industry Great saphenous vein Femoral Vein Middle Aged Surgery Primary varicose veins Clinical recurrence Quality of Life Female medicine.symptom Cardiology and Cardiovascular Medicine business |
| Zdroj: | European Journal of Vascular and Endovascular Surgery. 36(4):477-484 |
| ISSN: | 1078-5884 |
| DOI: | 10.1016/j.ejvs.2008.06.022 |
| Popis: | Objectives The aim of this study was to assess different techniques of saphenofemoral ligation in the treatment of primary varicose veins. Methods One hundred and eighty-two patients (210 legs) with primary saphenofemoral junction incompetence were randomised to standard saphenofemoral ligation (transfixion with an absorbable suture) (SSL) or flush saphenofemoral ligation (oversewing with 4/0 polypropylene) (FSL). All legs underwent additional great saphenous vein stripping and multiple phlebectomies. Patients underwent assessment preoperatively, and at 6 weeks, 1 year and 2 years postoperatively with clinical examination, duplex imaging and completion of the Aberdeen Varicose Vein Symptom Severity Score (AVVSSS). Results A total of 148 patients (172 legs) attended follow-up at 2 years postoperatively. Recurrent varicose veins were visible in 30 legs (33 per cent) in the SSL group and 26 legs (32 per cent) in the FSL group ( P = 0.90). Neovascularisation was present in 20 groins (22 per cent) in the SSL group and 15 groins (19 per cent) in the FSL group ( P = 0.57). Nine cases of neovascularisation in the SSL group and five in the FSL group directly resulted in clinical recurrence ( P = 0.37). Conclusions Flush ligation of the saphenofemoral junction confers no advantage over standard ligation with respect to clinical recurrence and neovascularisation. Registration number: ISRCTN20235689 ( http://www.controlled-trials.com ). |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect